References
- Schmid D, Ricci C, Behrens G, et al. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev. 2015 Sep;16(12):1042–54.
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clinicians. 2021 May;71(3):209–249.
- LeClair K, Bell KJL, Furuya-Kanamori L, et al. Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy. JAMA Intern Med. 2021 Oct 1;181(10):1351–1358. doi: 10.1001/jamainternmed.2021.4804
- Cao M, Li H, Sun D, et al. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020 May;40(5):205–210.
- Brito JP, Kim HJ, Han SJ, et al. Geographic distribution and evolution of thyroid cancer epidemic in South Korea. Thyroid. 2016 Jun;26(6):864–5.
- Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020 Jan;16(1):17–29. doi: 10.1038/s41574-019-0263-x
- Prete A, Borges de Souza P, Censi S, et al. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol (Lausanne). 2020;11:102. doi: 10.3389/fendo.2020.00102
- Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet (London, England). 2016 Dec 3;388(10061):2783–2795.
- Boueiz A, Lutz SM, Cho MH, et al. Genome-wide association study of the genetic determinants of emphysema distribution. Am J Respir Crit Care Med. 2017 Mar 15;195(6):757–771. doi: 10.1164/rccm.201605-0997OC
- Li J, Mahajan A, Tsai MD. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry. 2006 Dec 26;45(51):15168–15178.
- Ruan B, Feng X, Chen X, et al. Identification of a set of genes improving survival prediction in kidney renal clear cell carcinoma through integrative reanalysis of transcriptomic data. Dis Markers. 2020;2020:8824717. doi: 10.1155/2020/8824717
- Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet. 2009;60(1): Jan;Chapter 2:Unit 2.12. doi: 10.1002/0471142905.hg0212s60
- Dehal P, Boore JL, Holland P. Two rounds of whole genome duplication in the ancestral vertebrate. PLoS Biol. 2005 Oct;3(10):e314. doi: 10.1371/journal.pbio.0030314
- Mori Y, Yokota H, Hoshino I, et al. Deep learning-based gene selection in comprehensive gene analysis in pancreatic cancer. Sci Rep. 2021 Aug 13;11(1):16521. doi: 10.1038/s41598-021-95969-6
- Yang Z, Liu A, Xiong Q, et al. Prognostic value of differentially methylated gene profiles in bladder cancer. J Cell Physiol. 2019 Aug;234(10):18763–18772.
- Xiao M, Liang X, Yan Z, et al. A DNA-methylation-driven genes based prognostic signature reveals immune microenvironment in pancreatic cancer. Front Immunol. 2022;13:803962. doi: 10.3389/fimmu.2022.803962
- Carling T, Udelsman R. Thyroid cancer. Annu Rev Med. 2014;65(1):125–137. doi: 10.1146/annurev-med-061512-105739
- Zhu Q, Wang J, Zhang Q, et al. Methylation‑driven genes PMPCAP1, SOWAHC and ZNF454 as potential prognostic biomarkers in lung squamous cell carcinoma. Mol Med Rep. 2020 Mar;21(3):1285–1295.
- Ruan B, Feng X. Identification of a set of genes improving survival prediction in kidney renal clear cell carcinoma through integrative reanalysis of transcriptomic data. Dis Markers. 2020;2020:1–20. doi: 10.1155/2020/8824717
- Toniato A, Boschin I, Casara D, et al. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol. 2008 May;15(5):1518–1522.
- Ancker OV, Krüger M, Wehland M, et al. Multikinase inhibitor treatment in thyroid cancer. Int J Mol Sci. 2019 Dec 18;21(1):10. doi: 10.3390/ijms21010010
- Siegel RL, Miller KD. Cancer Stat. 2019 Jan;69(1):7–34. doi: 10.3322/caac.21551